Expert Interview
Another View: Understanding the disease, standard of care, current treatment paradigm and the unmet need in treating Melamoma with a focus on IOVA's LN-145
Ticker(s): IOVAAn oncologist who specializes in treating melamona
Please describe your current practice, roughly how many patients with melanoma do you currently manage?
Added By: c_adminWhat is your current firstline treatment option for melanoma?
Added By: c_adminWhat are your thoughts on TIL therapy in this space, particularly Iovance's LN-145?
Added By: c_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
